Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis

[1]  Hemant Ishwaran,et al.  Random Survival Forests , 2008, Wiley StatsRef: Statistics Reference Online.

[2]  Ce Zhang,et al.  Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.

[3]  Iver Petersen,et al.  Lung cancer: developments, concepts, and specific aspects of the new WHO classification , 2016, Journal of Cancer Research and Clinical Oncology.

[4]  G. Giaccone,et al.  Refining the treatment of NSCLC according to histological and molecular subtypes , 2015, Nature Reviews Clinical Oncology.

[5]  Gwénaël Le Teuff,et al.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Nguyen,et al.  Lineage factors and differentiation states in lung cancer progression , 2015, Oncogene.

[7]  J. Dudás.  Supportive and Rejective Functions of Tumor Stroma on Tumor Cell Growth, Survival, and Invasivity: The Cancer Evolution , 2015, Front. Oncol..

[8]  Daniel J. Brat,et al.  Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images , 2014, Laboratory Investigation.

[9]  L. Vannucci,et al.  Stroma as an Active Player in the Development of the Tumor Microenvironment , 2015, Cancer Microenvironment.

[10]  A. Errico.  Gastrointestinal cancer: FOLFOXIRI—improving outcomes of metastatic colorectal cancer , 2014, Nature Reviews Clinical Oncology.

[11]  Farhat Yaqub.  Intratumour heterogeneity in lung cancer. , 2014, The Lancet. Oncology.

[12]  A. Errico.  Lung cancer: Heterogeneity in space and time , 2014, Nature Reviews Clinical Oncology.

[13]  Hai Su,et al.  Novel image markers for non-small cell lung cancer classification and survival prediction , 2014, BMC Bioinformatics.

[14]  P. Thompson,et al.  Lung cancer neovascularisation: Cellular and molecular interaction between endothelial and lung cancer cells. , 2014, Immunobiology.

[15]  F. Markowetz,et al.  Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.

[16]  Advances in NSCLc: histologic distinction between adenocarcinoma and squamous cell carcinoma. , 2012, MLO: medical laboratory observer.

[17]  Elisabeth Brambilla,et al.  Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities , 2012, Clinical Cancer Research.

[18]  H. Maeda,et al.  Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  M. L. R. D. Christenson,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2012 .

[20]  Jeremy M. G. Taylor.  Random Survival Forests. , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  Andrew H. Beck,et al.  Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.

[22]  Zoe Wainer,et al.  Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  Christopher R. Cabanski,et al.  Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types , 2010, Clinical Cancer Research.

[24]  Akihiko Yoshizawa,et al.  A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.

[25]  M. J. van den Bent.  Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective , 2010, Acta neuropathologica.

[26]  Martin J. Bent,et al.  Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective , 2010, Acta Neuropathologica.

[27]  L. Chirieac,et al.  Prognostic significance of grading in lung adenocarcinoma , 2010, Cancer.

[28]  N. Tanner,et al.  Lung cancer: Progress in diagnosis, staging and therapy , 2010, Respirology.

[29]  A. Borczuk,et al.  Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma , 2009, The American journal of surgical pathology.

[30]  Mikhail Teverovskiy,et al.  Multifeature Prostate Cancer Diagnosis and Gleason Grading of Histological Images , 2007, IEEE Transactions on Medical Imaging.

[31]  Masahiro Tsuboi,et al.  The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. , 2007, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[32]  Anne E Carpenter,et al.  CellProfiler: free, versatile software for automated biological image analysis. , 2007, BioTechniques.

[33]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[34]  Vasilis Ntziachristos,et al.  Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  三好 立,et al.  Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis , 2003 .

[36]  N. Martinet,et al.  Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. , 2002, The Journal of laboratory and clinical medicine.

[37]  Jungsil Ro,et al.  Micropapillary Component in Lung Adenocarcinoma: A Distinctive Histologic Feature With Possible Prognostic Significance , 2002, The American journal of surgical pathology.

[38]  K. Sugimachi,et al.  High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. , 2001, Lung cancer.

[39]  P. Miřejovský,et al.  Cytokeratins and lung carcinomas. , 1999, Ceskoslovenska patologie.

[40]  W. D. Ray.  4. Modelling Survival Data in Medical Research , 1995 .

[41]  D. Gleason,et al.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.

[42]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .